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ABSTRACT 
Objective: The objective of this research work is to develop and evaluate mucoadhesive microspheres of an anti-migraine drug for 
sustained release. Materials and Methods:  Mucoadhesive microspheres were prepared by emulsification method using Sodium 
alginate (SA), polyvinyl pyrrolidone (PVP) and Chitosan in the various drug-polymer ratios of 1:1, 1:2 and 1:3. Nine  formulations 
were formulated and  evaluated for  possible drug polymer interactions, percentage yield, micromeritic properties, particle size, drug 
content, drug entrapment efficiency, drug loading, swelling index, In-vitro wash off test, in vitro  drug release, surface morphology 
and release kinetics. Results: The results showed that no significant drug polymer interaction in FTIR studies. Among all the 
formulations SF3 containing sodium alginate showed 77.18% drug release in 6hrs. Conclusion: Amongst the developed 
mucoadhesive microspheres, SF3 formulation containing sodium alginate exhibited slow and sustained release in a controlled 
manner and it is a promising formulation for sustained release of Sumatriptan succinate. 
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INTRODUCTION 
Mucoadhesive microspheres is one category of 
microspheres offers advantage of  increasing the 
residence time, efficient absorption, enhanced 
bioavailability, much more intimate contact with the 
mucus layer and reduction in frequency of drug 
administration. Hence, in this study an effective attempt 
was made to formulate the mucoadhesive microspheres 
of sumatriptan succinate as a model drug whose half-life 
is 2.5hrs with poor bioavailability of 14% due to first 
pass metabolism. The drug was chosen with an objective 
to sustain the drug action and to enhance the 
bioavailability. In order to improve the bioavailability, 
localization of the active component to a specific site 
mucoadhesive drug delivery systems have been utilized 
for the designing of microspheres using, Mucoadhesive 
polymers. Mucoadhesive polymers are water-soluble 
and water insoluble polymers, which are swellable 
network, joined by cross linking agents. These polymers 
possess optimal polarity to make sure that they permit 
sufficient wetting by the mucus and optimal fluidity that 
permits the mutual adsorption and interpenetration of 
polymer and mucus.
1,2,3
.
 
In this study sumatriptan 
succinate mucoadhesive microspheres are formulated 
and evaluated. 
MATERIALS AND METHODS  
Materials    
Sumatriptan succinate was obtained as gift sample from 
Sunglow pharmaceuticals Pvt Ltd, Puducherry. Sodium 
alginate, PVP and Chitosan were obtained from Loba 
Chemie Pvt Ltd. The other solvents like acetic acid, 
liquid paraffin (light), span 80, glutaraldehyde and n-
hexane were of Analytical Research (AR) Grade and 
obtained from Merck specialties Pvt. Ltd. 
Pre-formulation studies: 
Pre-formulation is considered as important phase where 
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researcher characterizes the physical, mechanical and 
chemical properties of new drug substance which helps 
to develop stable, effective and safe dosage forms. Not 
only for drug, but also they check possible interaction 
with various excipients.  
Organoleptic properties: 
 Colour: A small quantity of Sumatriptan succinate 
was taken in a butter paper and viewed in well-
illuminated place. 
 Taste and Odour: Very less quantity of 
Sumatriptan succinate was used to get the taste with 
the help of tongue as well as smelled to get the 
odour. 
Solubility studies of Sumatriptan succinate
 4
 
An excess quantity of Sumatriptan succinate is taken 
separately and added in 10ml of different solutions 
(methanol, alcohol, phosphate buffer and water). The 
solutions are shaken well for few minutes. Then the 
solubility is observed. The absorbance is measured using 
UV visible spectrophotometer at respective λmax. 
 Analysis of sumatriptan succinate
 4
 
100mg of Sumatriptan succinate is accurately weighed 
and transferred into a 100ml volumetric flask which 
contains 50ml buffer solution and the volume is made up 
to the mark by using buffer solution.  
From the stock solution, different concentrations of 
solutions are made and its absorbance is measured using 
UV visible spectrophotometer at respective λmax. 
Compatibility study between drug and polymer
 5
 
The FTIR spectra of the drug (alone), polymer (alone) 
and the drug-polymer (mixture) were recorded by the 
potassium bromide pellet method. The pellets were 
scanned over a wave number range of 4000–400 cm–1 in 
a Thermo scientific, FTIR instrument.  
Formulation of mucoadhesive microspheres 
Preparation of mucoadhesive microspheres by 
Emulsification method: 
An accurately weighed amount of drug is dispersed in an 
individual polymer solution namely Sodium alginate, 
Poly vinyl pyrrolidone and Chitosan. The drug polymer 
solutions are taken in the ratio of 1:1, 1:2, and 1:3 for all 
the three polymers.  The dispersions are emulsified in 
liquid paraffin containing 2% v/v span 80 and the 
solution is stirred using a mechanical stirrer at 1500-
2000 rpm for 1 hr.  Cross linking agent (Calcium 
Chloride and Glutaraldehyde) is added to the emulsion 
slowly and stirring is continued for 2 hrs (For Sodium 
alginate and Chitosan). The prepared microspheres are 
collected by filtration and washed 3 times with suitable 
solvent to remove liquid paraffin. Then, the 
microspheres are lyophilized to dry. 
Characterization of mucoadhesive microspheres 
Percent yield   
The prepared microspheres are evaluated for percentage 
yield. The percentage yield is calculated as per equation 
below, 
Percent yield 
=
                                        
                             
      
Micromeritic properties: 
The microspheres are characterized for micromeritic 
properties such as true density, tapped density, 
compressibility index and flow properties. The tapped 
density and compressibility index is determined by 
tapping method.  
Bulk density  
True density of microspheres is determined by pouring 
sample through a glass funnel into a graduated cylinder. 
The volumes occupied by the microspheres are recorded. 
True density is calculated. 
Bulk density (gm/ml)=
                            
                                  
 
Tapped density  
Tapped density of microspheres is determined by 
pouring sample through a glass funnel into a graduated 
cylinder. The tapped volume occupied by the 
microspheres is recorded.  Tapped density is calculated 
by using the formula  
Tapped density 
(gm/ml)=
                            
                                              
 
Angle of repose    
Flow ability of the prepared microspheres is determined 
by calculating angle of repose by fixed funnel method. A 
funnel with 10 mm inner diameter of stem is fixed at a 
height of 2 cm. over the platform. About 10 gm of 
sample is slowly passed along the wall of the funnel till 
the tip of the pile formed and touches the steam of the 
funnel. A rough circle is drawn around the pile base and 
the radius of the powder cone is measured. Angle of 
repose is calculated by using the following formula, 
θ = tan- 1(h/r)         
   Where,   θ = Angle of repose   
 h = Height of the pile   
 r = Average radius of the powder cone  
Carr’s Index  
It is also one of the simple methods to evaluate flow 
property of powder by comparing the bulk density and 
tapped density. A useful empirical guide is given by the 
Carr’s compressibility.    
Carr’s index =
               –            
               
 x 100 
Particle size analysis: 
The Mucoadhesive microspheres are examined by 
optical microscope. The freshly prepared suspension of 
microspheres is examined on an optical microscope and 
size of the microspheres is measured by using a pre-
calibrated ocular micrometer and stage micrometer.
6 
Drug entrapment efficiency:
7
 
Drug loaded microspheres (100 mg) are powdered and 
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transferred into 100 ml volumetric flask dissolved in 10 
ml of solvent and the volume is made up with suitable 
dissolution medium. The resultant dispersion was kept 
for 24 hrs for complete dissolution and filtered through a 
0.45 µm membrane filter. The drug entrapment 
efficiency is determined spectrophotometrically after 
appropriate dilutions at respective λmax. The drug 
entrapment efficiency is calculated by the following 
equation, Drug Entrapment Efficiency = Amount of drug 
in microspheres / Amount of drug added initially × 100. 
Determination of drug content in microspheres    
Drug loaded microspheres (100 mg) are powdered and 
transferred into 100 ml volumetric flask dissolved in 10 
ml of solvent and the volume is made up with suitable 
dissolution medium. The drug content is determined 
spectrophotometrically after appropriate dilutions at 
respective λmax. The drug content is calculated by the 
following equation, 
Drug content = Amount of drug in microspheres / 
Amount of microspheres × 100 
Determination of drug loading in microspheres 
The drug loading in the microspheres is estimated by 
using the formula    
L = Qm/Wm × 100 
Where,    
 L   = Percentage of drug loading in the 
microspheres                        
Wm= Weight of microspheres in grams                           
 Qm   = Quantity of drug present in Wm grams 
of microspheres. 
Swelling index:
 8
 
The swelling index is a property measured to know the 
behaviour of polymer in physiological solution. It is 
determined by keeping the microspheres in buffer 
solution for 24 h and washed. The swelling index is 
calculated using formula, 
α = 
     
  
 
 Where, 
α is swelling index, W1 is weight of microspheres before 
swelling and W2 is weight of microspheres after 
swelling. 
In-vitro wash off test (mucoadhesion test):
 9
 
The mucoadhesive properties of the microspheres were 
evaluated by in vitro wash-off test. A 4cm x 4cm piece 
of goat intestinal mucosa was tied onto the paddle 
bottom of a USP dissolution test apparatus - II using a 
thread. A weighed amount of microspheres, i.e. 100mg 
were spread onto the wet, rinsed tissue specimen. The 
dissolution test apparatus was operated such that the 
tissue specimen was rotated at a speed of 25 rpm in 
phosphate buffer (pH 7.4). At the end of 6
th
 hour, the 
amount of microspheres still adhering onto the tissue 
was scrapped and weighed. The percentage 
mucoadhesion of the microspheres was determined 
using the following formula: 
Percentage mucoadhesion = 
  
  
 × 100 
Where, 
 W1is weight of microspheres applied  
 W2is weight of microspheres still adhered  
In vitro drug release study 
The drug release is studied by using USP type II 
apparatus at 37 ± 0.5
0
C and at 100 rpm in phosphate 
buffer pH7.4. Five ml of the sample solution is 
withdrawn at predetermined time intervals, filtered, 
diluted suitably and analyzed spectrophotometrically. 
Equal amount of the fresh dissolution medium is 
replaced immediately after withdrawal of the test 
sample. Percentage drug dissolved at different time 
intervals is calculated using the Lambert-Beer’s 
equation. The result is obtained in triplicate and the 
average value reported.
10 
In-vitro drug release study of selected mucoadhesive 
microspheres of sumatriptan succinate and marketed 
conventional tablets 
The In-vitro drug release values of selected 
mucoadhesive microspheres of sumatriptan succinate 
were compared with the marketed conventional tablet. 
Surface topography by Scanning Electron 
The surface morphology and structure are visualized by 
scanning electron microscopy (SEM) 
10 
Release Kinetics Studies 
11
 
Drug release pattern from microspheres: 
In order to understand the mechanism and kinetics of 
drug release, the results of the in vitro drug release study 
are fitted with various kinetic equations like zero order, 
first order and Higuchi model. In order to define a model 
which will represent a better fit for the formulation. 
1. Zero – order model: Drug dissolution from dosage 
forms that do not disaggregate and release the drug 
slowly can be represented by the equation:  
Qt = Q0 + K0t  
Where,  
Qt is the amount of drug dissolved in time t,   
Q0 is the initial amount of drug in the solution,   
K0 is the zero order release constant and  
t is time in hours.  
Expressed in units of concentration/time.  
Graph: X- axis is time in hours and Y- axis is % 
cumulative drug release.  
2. First order model: The release of the drug which 
followed first order kinetics can be expressed by the 
equation:  
Log Qt = log Q0 + Kt / 2.303  
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 Where,    
Q0 is the initial concentration of drug,  
Qt is cumulative amount of drug released per unit 
surface area,   
k is the first order rate constant and  
t is the time.  
Graph: X- axis is time in hours and Y- axis is log % 
cumulative drug release. 
3. Higuchi model: Higuchi model describes the drug 
release from several typed of matrices initially 
conceived for planar systems, then extended to different 
geometrics and porous systems. It was derived by 
higuchi in 1961. For higuchi release kinetics equation is,   
Q = KH t 0.  
Where,  
Q is amount of drug released per unit surface area of the 
dosage form  
KH is Higuchi release rate constant and  
t is time.  
4. Korsmeyer – Peppas model: Koresmeyer derived a 
simple relationship which describes drug release from a 
polymeric system. To find out the mechanism of drug 
release, first 60% drug release data was fitted in 
Koresmeyer – Peppas model equation,  
(Mt/M) = Km tn  
Where,  
Mt is amount of drug released at time t,  
M is total amount of drug in dosage form,  
Km is kinetic constant,  
n is diffusion and release exponent and t is time in hours. 
RESULTS AND DISCUSSIONS 
Pre Formulation Studies   
Preformulation studies were performed for the drug to 
rule out the interaction with the Polymers used for 
formulating mucoadhesive microspheres. The various 
preformulation parameters like organoleptic 
characteristics, analysis of API and compatibility studies 
were studied and results were shown below. 
Organoleptic properties: 
 Colour: White to off-white.   
 Taste & odour: Bitter taste and Odourless. 
Analysis of Sumatriptan succinate:  
Standard curve of Sumatriptan succinate: 
The UV spectrophotometric method of analysis showed 
linearity range from 0-10 μg/ml for Sumatriptan 
Succinate in phosphate buffer pH 7.4 at 226nm 
wavelength. The regression coefficient (R
2)
 of 
Sumatriptan Succinate in the solution was found to be 
0.999 and was within the limits as shown in as shown in 
Table-1 and in Fig-1. 
Table 1: Absorbance of Sumatriptan Succinate 
S. 
No 
Concentration 
(µg/ml) 
Absorbance at 226 
nm 
1 0 0 
2 2 0.250 
3 4 0.545 
4 6 0.810 
5 8 1.120 
6 10 1.420 
 
 
Figure 1: Calibration Curve of Sumatriptan 
Succinate 
 
Compatibility study between drug and polymer by 
FTIR 
The FTIR spectrophotometric method was used to study 
the compatibility between the drug and polymers. FTIR 
spectrum of pure drug, drug polymer mixture was taken 
and compared as shown in Fig-2 to 6. From the spectra it 
was analyzed that Sumatriptan Succinate showed 
characteristic bands at 3271cm
-1
 for N-H stretching, 
1641cm
-1
  for N-H bending, 1300cm
-1
  for C-N 
vibration, 1121cm
-1
  for C-N stretching, 1077cm
-1
  for 
S=O Stretching. 
On comparing the spectrum of pure drug with drug and 
polymer mixture all the characteristic peaks of drug 
were found to be similar with the IR spectra of drug 
polymer mixture indicated the absence of drug-polymer 
interactions and showed the suitability of the polymers 
used for the preparation. 
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Figure 2: FTIR spectra of sumatriptan succinate  
 
Figure 3:  FTIR spectra of sumatriptan succinate and sodium alginate. 
 
Figure 4:  FTIR spectra of sumatriptan succinate and Polyvinylpyrrolidone. 
 
Figure 5:  FTIR spectra of sumatriptan succinate and chitosan 
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Figure 6: FTIR spectra of sumatriptan succinate with sodium alginate, Polyvinylpyrrolidone, and chitosan 
 
Formulation of Mucoadhesive Microspheres 
Preparation of mucoadhesive microspheres by 
Emulsification method: 
Mucoadhesive microspheres of sumatriptan succinate 
were prepared by emulsification method using sodium 
alginate, poly vinyl pyrrolidone and chitosan. The drug-
polymer solutions were taken in the ratio of 1:1, 1:2, and 
1:3 respectively and were mentioned in Table-2. 
 
Table 2: Formulation of Mucoadhesive Microspheres 
Formulation 
Code 
Drug                
(mg) 
Polymer  
(mg) 
Liquid 
paraffin (ml) 
Span 80 
(ml) 
Calcium 
chloride (ml) 
Glutaraldehyde       
(ml) 
SF1 100 100 25 0.5 25 - 
SF2 100 200 25 0.5 25 - 
SF3 100 300 25 0.5 25 - 
PF1 100 100 50 0.5 - - 
PF2 100 200 50 0.5 - - 
PF3 100 300 50 0.5 - - 
CF1 100 100 50 0.5 - 4 
CF2 100 200 50 0.5 - 4 
CF3 100 300 50 0.5 - 4 
 
Characterization of Mucoadhesive Microspheres 
Percentage Yield  
The percentage yield of the mucoadhesive microspheres 
of sumatriptan succinate was calculated and the results 
were shown in the Table-3. From the result, it was 
observed that the percentage yield of all the preparations 
such as SF1, SF2, SF3, PF1, PF2, PF3, CF1, CF2, and 
CF3 was in the range of 87.5 to 98.62%. Further, it was 
observed that an increase in the polymer ratio in the 
formulation, the percentage yield also increased in all 
the formulations. 
 
Table 3: Characterization of sumatriptan succinate mucoadhesive microspheres  
S.no Formulation 
code 
Percentage 
yield (%) 
Mean particle 
size (µm) 
Drug 
Content (%) 
Drug entrapment 
efficiency (%) 
Drug loading 
Capacity (%) 
1 SF1 90.54 31 81.68 ± 1.62 71.48 ±1.23 35.74 ±1.32 
2 SF2 93.66 37.50 76.42 ±1..23 69.28 ±1.06 23.09 ±1.54 
3 SF3 98.62 40.50 73.41 ±1.39 66.46 ±1.53 16.61 ±1.25 
4 PF1 87.5 17.50 81.76 ±1.65 87.18 ±1.54 43.59 ±1.06 
5 PF2 93 19.50 77.91 ±1.51 85.83 ±1.36 28.61 ±1.15 
6 PF3 94.37 23 73.57 ±1.72 81.68 ±1.56 20.45 ±1.39 
7 CF1 92.5 32.5 76.31 ±1.63 76.74 ±1.41 38.37 ±1.71 
8 CF2 95 38.75 73.32 ±1.56 73.32 ±1.31 24.44 ±1.62 
9 CF3 97.5 42.50 70.21 ±1.64 68.96 ±1.62 17.55 ±1.34 
Mean±standard deviation (n=3) 
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Micromeritic properties 
The micromeritic properties such as bulk density, tapped 
density, Hausne’s ratio, compressibility index and angle 
of repose were carried out and the results were shown in 
the Table-4. From the study, it was observed that the 
bulk and tapped density, Hausner’s ratio, Carr’s index 
and angle of repose of all the preparations such as SF1, 
SF2, SF3, PF1, PF2, PF3, CF1, CF2, CF3 was in the 
range of 0.25 to 0.86 g/ml, 0.31 to 0.86 g/ml, 1.2 to 
1.45, 16 to 30%, 2.90 to 11.75 θ respectively.  
Further, it was observed that the values of bulk density 
and tapped density in all the formulations were within 
the limit, an increase in the Hausner’s ratio was 
observed with mucoadhesive microspheres of 
sumatriptan succinate using Polyvinylpyrrolidone as 
polymer than with the other polymers may be due to its 
hydrophilic nature. The low values of angle of repose 
and Carr’s index was observed in all the formulations of 
mucoadhesive microspheres of sumatriptan succinate 
may be  due to more fineness of the formulation and 
mucoadhesive nature of the polymer. 
  
Table 4: Micromeritic properties of sumatriptan succinate mucoadhesive microspheres 
Formulation 
Code 
Bulk 
density(g/ml) 
Tap 
density(g/ml) 
Hausner’s ratio Carr’s index 
(%) 
Angle of repose 
SF1 0.41 ±0.24 0.51 ±0.21 1.24 ±0.09 19.60 ±0.8 8.65 ±0.15 
SF2 0.52 ±0.59 0.65 ±0.25 1.25 ±0.04 20 ±0.6 9.51 ±0.31 
SF3 0.55 ±0.45 0.66 ±0.65 1.2 ±0.02 16.66 ±0.7 11.75 ±0.25 
PF1 0.58 ±0.26 0.85 ±0.95 1.45 ±0.06 30.90 ±0.6 2.90 ±0.61 
PF2 0.63 ±0.65 0.86 ±0.18 1.39 ±0.06 28.14 ±0.8 3.87 ±0.18 
PF3 0.66 ±0.57 0.83 ±0.56 1.33 ±0.05 26.01 ±0.4 3.95 ±0.24 
CF1 0.25 ±0.43 0.31 ±0.21 1.24 ±0.09 19.35 ±0.9 5.59 ±0.35 
CF2 0.28 ±0.19 0.36 ±0.36 1.28 ±0.08 22.22 ±0.5 6.51 ±0.26 
CF3 0.32 ±0.32 0.40 ±0.41 1.25 ±0.05 20 ±0.8 7.54 ±0.15 
Mean±standard deviation (n=3) 
Particle Size Analysis 
All the formulations were subjected to particle size 
analysis by optical microscopic method and the results 
were tabulated in the Table-3. From the study it was 
observed that the mean particle size was significantly 
increased with increase in the polymer concentration. 
The particle size in all the formulations was in the order 
of, 
CF1-CF3> SF1-SF3 > PF1-PF3. 
The small particle size was observed with mucoadhesive 
microspheres of sumatriptan succinate with PVP when 
compared with the other polymers may be due to the 
formation of unstable nuclei. 
Drug content, Drug Entrapment Efficiency and Drug 
loading of mucoadhesive microspheres of 
sumatriptan succinate 
The results of drug content, drug entrapment efficiency 
and drug loading of mucoadhesive microspheres of 
sumatriptan succinate were enlisted in Table-3. The 
percentage of drug content, drug entrapment efficiency 
and drug loading for all the formulations SF1-SF3, PF1-
PF3, CF1-CF3 was in the range of 70.21% to 81.68%, 
66.46 %to 87.18% and 16.61% to 43.59% respectively. 
From the study it was observed that an increase in the 
concentration of polymer in all the formulations,   
results in decrease in the percentage of drug content, 
drug entrapment efficiency and drug loading. The reason 
may be due to loss of drug during washing, adherence of 
drug on the walls of the beaker and stirrer, addition of 
insufficient amount of cross linking agent and duration 
of stirring. 
Higher percentage of drug content, drug entrapment 
efficiency and drug loading was observed with PVP 
mucoadhesive microspheres of sumatriptan succinate 
may be due to its hydrophilic nature. 
Swelling index 
The swelling index demonstrated the ability of the 
mucoadhesive microspheres to get swell at the 
absorbing surface by absorbing fluid at the site of 
absorption. It is also used to check the water absorption 
property of the polymers. The swelling index for all the 
formulation was calculated and results were shown in 
Table-5. From the study it was observed that the 
swelling index value was in the range of 1.1 to 
2.94mg/ml, indicated that an increase in the 
concentration of polymer produced, an increase in the 
swelling property of microspheres. Among the 
polymers, swelling index value was high with sodium 
alginate formulations than with the other polymers. May 
be due to more water absorbing nature of sodium 
alginate which absorb water within its porous structure. 
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Table 5: Swelling index and percentage mucoadhesion of sumatriptan succinate mucoadhesive microspheres 
S.no Formulation Swelling index 
(mg/ml) 
Percentage 
Mucoadhesion 
1 SF1 2.43 ±0.51 54 ±1.45 
2 SF2 2.73 ±0.36 61 ±1.53 
3 SF3 2.94 ±0.54 72 ±1.65 
4 PF1 1.1 ± 0.56 21 ±1.34 
5 PF2 1.31 ± 0.45 40 ± 1.26 
6 PF3 1.42 ± 0.49 79 ± 1.47 
7 CF1 1.24 ±0.42 45 ± 1.49 
8 CF2 1.56 ±0.35 79 ± 1.58 
9 CF3 1.75 ±0.52 85 ± 1.61 
Mean±standard deviation (n=3) 
SEM analysis 
Morphological analysis of the mucoadhesive 
microspheres of sumatriptan succinate (SF3) was carried 
out using scanning electron microscopy (SEM) and the 
result were shown Fig-7.The SEM photographic result 
reveals that the microspheres were almost spherical in 
shape and rough surface. 
 
 
Figure 7: Scanning electron microscopy of mucoadhesive microspheres of sumatriptan succinate (SF3) 
 
In-vitro wash off test (mucoadhesion test): 
In-vitro wash off test is used to determine the 
mucoadhesion behaviour of the polymers. The test was 
carried out for all the formulations and the result test 
was enlisted in Table-5.  From the result it was found 
that the percentage of mucoadhesion for all the 
formulations was in the range of 21 to 85% showed 
good mucoadhesion nature and the values also indicated 
that an increase in the concentration of polymer resulted 
in an increase in the percentage of mucoadhesion of 
microspheres. Among the formulations the percentage of 
mucoadhesion was higher with chitosan microspheres 
due to strong electrostatic interactions of the Cationic 
polymers with the negatively charged mucin present in 
the mucosal layer whereas sodium alginate and PVP 
mucoadhesion with mucin mucosal layer is due to 
hydrogen bonding. 
In-vitro drug release studies: 
The percentage cumulative drug release was calculated 
and the values were shown in Table-6 and in Fig-8. 
At 8
th
 hr the percentage cumulative drug release for SF1, 
SF2, and SF3 formulations was found to be 52.48%, 
53.19%, 64.17%, respectively. For PF1, PF2, PF3 
formulations, the percentage cumulative drug release 
was in the order of 30.29%, 35.48%, and 37.68% 
respectively and for CF1, CF2, CF3 formulations the 
percentage cumulative drug release was in the order of 
40.64%, 32.75%, 29.34%respectively. Among all the 
formulations sodium alginate microspheres showed 
increased and sustained drug release. Further among the 
three sodium alginate microspheres, SF3 showed 
increased amount of percentage drug release due to 
increased drug polymer ratio and the mechanism of drug 
release is due to swelling and erosion. 
The percentage cumulative drug release for PVP was 
less than sodium alginate microspheres of sumatriptan 
succinate may be due to its high viscous and 
mucoadhesive nature. The percentage cumulative drug 
release for chitosan microspheres was less than sodium 
alginate microspheres but greater than PVP 
microspheres due to its high mucoadhesion nature. 
Hence among all the formulations, SF3 was chosen for 
further study due to its increased drug release. 
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Table 6: Cumulative percentage drug release for mucoadhesive microspheres of sumatriptan succinate 
Time 
(min) 
SF1 SF2 SF3 PF1 PF2 PF3 CF1 CF2 CF3 
10 21.54 
±0.61 
23.05 
±1.03 
27.07 
±1.23 
12.32 
±1.26 
12.56 
±1.30 
12.50 
±1.32 
14.15 
±1.32 
20.44 
±1.01 
12.08 
±1.31 
20 23.60 
±0.53 
27.96 
±1.66 
31.59 
±1.02 
12.94 
±1.54 
13.49 
±1.67 
16.61 
±1.21 
16.63 
±1.02 
21.03 
±0.94 
12.94 
±1.02 
30 25.77 
±0.42 
28.57 
±1.23 
33.74 
±0.99 
13.56 
±1.56 
15.69 
±1.48 
17.15 
±1.05 
19.74 
±1.31 
21.93 
±0.84 
13.44 
±1.32 
45 27.06 
±0.65 
31.61 
±1.36 
36.28 
±0.98 
14.76 
±1.22 
17.86 
±1.35 
18.12 
±1.34 
23.09 
±1.04 
23.29 
±0.67 
14.27 
±1.04 
60 30.79 
±0.74 
34.90 
±1.01 
39.96 
±0.55 
15.05 
±1.32 
21.54 
±1.25 
21.18 
±1.24 
28.54 
±1.12 
24.19 
±1.24 
14.76 
±1.52 
120 32.01 
±0.65 
38.63 
±1.23 
43.48 
±0.68 
16.12 
±1.05 
22.25 
±1.54 
 3.55    
±1.54 
31.67 
±1.02 
24.99 
±1.07 
16.32 
±1.34 
240 36.34 
±0.45 
41.43 
±1.54 
46.42 
±0.67 
17.54 
±1.09 
24.25 
±1.64 
25.66     
±1.36 
34.30 
±1.17 
27.57 
±1.11 
18.57 
±1.25 
300 40.76 
±0.49 
43.29 
±1.02 
50.19 
±1.41 
20.81 
±1.34 
27.23 
±1.35 
27.51     
±1.54 
35.56 
±1.19 
28.29 
±1.20 
23.47 
±1.32 
360 44.64 
±0.57 
46.18 
±1.61 
54.21 
±1.03 
26.57 
±1.24 
31.52 
±1.91 
33.71 
±1.24 
38.47 
±1.31 
29.49 
±0.97 
25.08 
±1.31 
420 46.01 
±1.34 
48.95 
±1.03 
59.32 
±1.30 
28.21 
±1.09 
33.25 
±1.20 
35.45 
±1.09 
39.59 
±1.64 
31.02 
±1.36 
27.15 
±1.64 
480 48.68 
±1.03 
53.19 
±1.24 
64.17 
±1.05 
30.29 
±1.64 
35.48 
±1.03 
37.68 
±1.64 
40.64 
±1.31 
32.75 
±1.09 
29.34 
±1.31 
Mean±standard deviation (n=3) 
 
 
Figure 7: Cumulative percentage drug release for mucoadhesive microspheres of sumatriptan succinate 
 
Table 7: Drug release kinetics data for mucoadhesive microspheres of sumatriptan succinate (SF3) 
Formulation 
Code 
Zero order   
R
2
 
First order 
R
2
 
Higuchi 
diffusion kinetics 
R
2
 
Korsmeyar-
peppas 
Hixson Crowell 
R
2
 
 R
2
n 
SF3 0.892 0.830 0.956 0.984 1.26 0.6791 
 
In-vitro drug release of mucoadhesive microspheres 
of sumatriptan succinate (SF3) with marketed 
conventional tablets: 
The percentage cumulative drug release for 
mucoadhesive microspheres of sumatriptan succinate 
SF3) and marketed conventional tablets values were 
shown in Fig-9. The percentage cumulative drug release 
for the marketed tablets was 99% at 30 min while SF3 
formulation showed 64.17% drug release at 8
th
 hr. 
Kinetics of Drug release 
The kinetics of In-vitro drug release for mucoadhesive 
microspheres of sumatriptan succinate (SF3) was 
determined by applying the drug released data to various 
kinetic models such as zero order, first order, Higuchi 
0 
10 
20 
30 
40 
50 
60 
70 
0 100 200 300 400 500 600 
%
 c
u
m
u
la
ti
ve
 d
ru
g 
re
le
as
e
 
time(min) 
Cumulative percentage drug release for mucoadhesive microspheres of 
sumatriptan succinate 
SF1 SF2 SF3 PF1 PF2 PF3 CF1 CF2 CF3 
Ilaveni et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2018; 8(5):465-474           
ISSN: 2250-1177                                                                              [474]                                                                             CODEN (USA): JDDTAO 
and Korsmeyer- Peppas. The result obtained was 
represented in Table-7 and in Fig-10. 
In the present study, the release profile of the SF3 
formulation follows Korsmeyar-peppas equation with 
the ‘R2’ value-0.984. Further the ‘n’ values of 
Korsmeyar peppas was 1.26. Therefore the most 
probable mechanism of drug release was super case II 
transport. 
 
Figure 9: In-vitro drug release of mucoadhesive 
microspheres of sumatriptan succinate (SF3) with 
marketed conventional tablet 
 
Figure 10: Korse-meyer Peppas Equation for 
mucoadhesive microspheres of sumatriptan succinate 
(SF3) 
CONCLUSION 
Varying degrees of sustained release was obtained from   
sumatriptan succinate mucoadhesive microspheres 
prepared from sodium alginate, PVP and chitosan by 
emulsification method. Among all the formulations 
developed sodium alginate mucoadhesive microspheres 
showed the most drug sustaining and it is promising for 
sustained release of sumatriptan succinate. 
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